A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of asthma for at least 6 months
Prescribed daily use of glucocorticosteroids for at least 3 months prior to visit one
You may not be if
Respiratory infection affecting asthma within 30 days prior to study
Intake of oral, rectal, or parenteral glucocorticosteroids within 30 days prior to study
Any significant disease or disorder that may jeopardize the safety of the patient
Clareo Health | A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®
